Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Triamcinolone Acetonide vs Bevacizumab Alone in Macular Edema Secondary to CRVO
NCT04812977Completed
- Sponsor
- Hayatabad Medical Complex
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of triamcinolone in macular edema (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Visual Acuity at 6 months. Started Jun 2018; status: completed.
02
Drugs
triamcinolone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT04812977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04812977.